quant Healthcare Fund · Regular · Growth
NAV
₹18.3644
as of 13 Nov 2026
Expense Ratio
3.00%
AUM
₹412 Cr
Lumpsum returns (CAGR)
- 1Y
- +18.68%
- 3Y
- +19.42%
- 5Y
- —
- Since Inception
- +20.05%
SIP returns (XIRR)
- 1Y
- +29.30%
- 3Y
- +14.21%
- 5Y
- —
- Since Inception
- +15.31%
What history actually did — last 3 years (Nov 2023 – Nov 2026)
A ₹5,000 monthly SIP for the last 3 years (Nov 2023 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹2,17,781 today — ₹1,80,000 invested, 13.4% XIRR.
₹1,80,000
Invested
₹2,17,781
Value today
13.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 3 years (Nov 2023 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 3 years ago would be ₹1,70,295 today (19.4% CAGR).
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹2,17,781 in this fund vs ₹1,95,242 in the benchmark — outperformance of ₹22,539.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 3 years (Nov 2023 – Nov 2026) (4 Jun 2024) would be ₹1,37,293 today (1.37×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.46
Sharpe Ratio
+0.09
Alpha
0.81
Beta
0.48
Sortino
15.23%
Std Dev
-13.27%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Sept 2026- Pharmaceuticals & Biotechnology58.11%
- Food Products4.90%
- Personal Products3.45%
- Consumer Durables0.59%
- Fertilizers & Agrochemicals0.26%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about quant Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Glaxosmithkline Pharmaceuticals Ltd9.69%
- 2Zydus Lifesciences Limited9.39%
- 3Strides Pharma Science Ltd9.04%
- 4Pfizer Ltd7.37%
- 5Alivus Life Sciences6.21%
- 6Ipca Laboratories Ltd5.98%
- 7Aurobindo Pharma Limited5.09%
- 8Zydus Wellness Ltd4.90%
- 9Colgate-Palmolive (India) Ltd3.45%
- 10Natco Pharma Ltd3.01%
What this fund does
quant Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
quant Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by quant Mutual Fund. The fund has been operational for over 3 years. It manages assets worth ₹412 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY HEALTHCARE INDEX TRI. The current expense ratio is 3.00%.